$ACMR

ACM Research, Inc.

AlphAI earnings readsecond quarter 2026 · AUG 7ACM Research Reports Second Quarter 2026 ResultsVerdict: strong

Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.

0
0
1
—
$10.6M
Wang David H
100%
See all $ACMR insider activity →

ACM Research’s Operating Subsidiary ACM Research (Shanghai) Provides Backlog Data

ACM Research (NASDAQ: ACMR) announced its subsidiary, ACM Research (Shanghai), reported a backlog of RMB 17.1 billion (USD 2.5 billion), up 88.2% year-over-year. The backlog includes orders for semiconductor processing tools. Full financial results for the nine months ended September 30, 2026, will be released on October 28, 2026.

Does Earnings Beat Change The Bull Case For ACM Research Stock (ACMR)?

ACM Research (ACMR) reported revenue of $1.04B and net income of $150.2M, beating analyst estimates. The company projects $2.0B in revenue and $316M in earnings by 2029. Investors focus on execution, China exposure, and R&D spend. Analysts' views vary, with some seeing 78% upside and others 18% downside.

ACMR sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 1 news story mentioning ACMR (ACM Research, Inc.). Coverage has skewed bearish: 0 bullish, 0 neutral, and 1 bearish.

Recent ACMR coverage spans earnings, financial news and market movers.

In the last 30 days, ACMR insiders filed 9 SEC Form 4 transactions — no purchases and 9 sales ($10.6M). The most active reporter was Wang David H, See Remarks, with 9 filings. 100% of those filings were made under pre-arranged Rule 10b5-1 plans.

What's driving ACMR

AlphAI scores every news story that mentions ACMR with an AI model for sentiment and relevance, and aggregates insider trades from ACM Research, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $ACMR

Score

AI Sovereignty Becomes a New National Security Battleground: Morgan Stanley Names SpaceX and 4 Other Beneficiary Stocks, with Upside Potential Topping 100% — BigGo Finance

Morgan Stanley identifies SpaceX, ACM Research, Amkor Technology, Alibaba, and KLA as key beneficiaries of the AI sovereignty trend. The bank assigns price targets with upside potential ranging from 21% to 105%, highlighting the strategic importance of AI infrastructure for national security and economic competitiveness.

ACM Research (NASDAQ: ACMR) unit’s orders surge past 100% with 42–48% margin outlook

ACM Research (Shanghai) reported a 105% year-over-year increase in new orders for the first half of 2026, with growth across electroplating, cleaning, and advanced packaging equipment. The company expects gross margins to remain between 42% and 48%. Significant orders include panel-level electroplating systems for delivery in 2026 and 2027. ACM Shanghai also highlighted rapid growth in mature-node semiconductor manufacturing and AI-related equipment demand.

Top China Tech Plays Worth Adding to Your Portfolio Right Now

China's tech sector shows resilience despite tariffs and geopolitical tensions. Key companies like ACM Research (ACMR), GDS Holdings (GDS), Kingsoft Cloud (KC), and Taiwan Semiconductor (TSM) are highlighted as investment opportunities. TSM reported strong Q3 2026 guidance, with revenues projected at $44.6-$45.8 billion. ACMR raised full-year 2026 revenue guidance to $1.125-$1.175 billion. GDS increased revenue and EBITDA guidance, driven by AI demand. KC saw AI cloud revenues grow 82% year over

$EVMNMed

This Atlassian Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - ACM

Analysts initiated coverage on several companies: Needham rated Evommune (EVMN) Buy with a $28 target, Daiwa rated ACM Research (ACMR) Buy with a $136 target, Wolfe Research rated Harmony Biosciences (HRMY) Outperform with a $60 target, RBC rated Atlassian (TEAM) Outperform with a $215 target, and RBC rated JFrog (FROG) Outperform with a $118 target.

Related tickers